| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M301100200 |
| P8608 | Fatcat ID | release_7whtltib4vb4bo3vvkrurbp6aa |
| P698 | PubMed publication ID | 12670950 |
| P2093 | author name string | Richard B Kim | |
| Allan W Wolkoff | |||
| J Roy Chowdhury | |||
| Pijun Wang | |||
| P2860 | cites work | Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6 | Q28141205 |
| Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans | Q28209488 | ||
| Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemia | Q28317256 | ||
| Hepatic bilirubin uptake in the isolated perfused rat liver is not facilitated by albumin binding | Q33822154 | ||
| Hepatic organic anion uptake in the rat | Q34114340 | ||
| Role of chloride and intracellular pH on the activity of the rat hepatocyte organic anion transporter | Q34186745 | ||
| Influence of Cl- on organic anion transport in short-term cultured rat hepatocytes and isolated perfused rat liver | Q34568395 | ||
| The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents | Q40318472 | ||
| Stable Inducible Expression of a Functional Rat Liver Organic Anion Transport Protein in HeLa Cells | Q49035706 | ||
| Functional characterization of the basolateral rat liver organic anion transporting polypeptide. | Q49093752 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 20695-9 | |
| P577 | publication date | 2003-06-06 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transport | |
| P478 | volume | 278 |
| Q85951738 | Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms |
| Q35429777 | Development of a high-affinity inhibitor of the prostaglandin transporter |
| Q38927197 | Drug- and Drug Abuse-Associated Hyperbilirubinemia: Experience With Atazanavir |
| Q33776950 | Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants |
| Q34117182 | Functional induction of the cystine-glutamate exchanger system Xc(-) activity in SH-SY5Y cells by unconjugated bilirubin |
| Q35889227 | Genetics and the risk of neonatal hyperbilirubinemia: commentary on the article by Huang et al. on page 682. |
| Q46990759 | Hormonal regulation of hepatic multidrug resistance-associated protein 2 (Abcc2) primarily involves the pattern of growth hormone secretion |
| Q34612244 | Impact of OATP transporters on pharmacokinetics |
| Q43638470 | In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia |
| Q94503844 | Interindividual Diversity in Expression of Organic Anion Uptake Transporters in Normal and Cirrhotic Human Liver |
| Q47272832 | Membrane Transporters for Bilirubin and Its Conjugates: A Systematic Review. |
| Q37137527 | Organic anion uptake by hepatocytes |
| Q42726145 | PharmGKB very important pharmacogene: SLCO1B1. |
| Q34155271 | Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease |
| Q37121662 | Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. |
| Q34207748 | Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome |
| Q28277932 | Risk factors for severe hyperbilirubinemia in neonates |
| Q51369164 | UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association? |
Search more.